Open AccessHormonal Gender Reassignment Treatment for Gender Dysphoria
Author(s) -
Gesine Meyer,
Ute Boczek,
Jörg Bojunga
Publication year - 2020
Publication title -
deutsches ärzteblatt international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.436
H-Index - 60
ISSN - 1866-0452
DOI - 10.3238/arztebl.2020.0725
Subject(s) - gender dysphoria , medicine , cyproterone acetate , gender identity disorder , transgender , cyproterone , hormone therapy , spironolactone , sex reassignment surgery (male to female) , testosterone (patch) , distress , dysphoria , medroxyprogesterone acetate , gender identity , gynecology , psychiatry , clinical psychology , hormone , androgen , vagina , cancer , vaginoplasty , breast cancer , surgery , psychology , anxiety , psychoanalysis , social psychology , heart failure
No data are available at present on the prevalence of gender dysphoria (trans-identity) in Germany. On the basis of estimates from the Netherlands, it can be calculated that approximately 15 000 to 25 000 persons in Germany are affected. Persons suffering from gender dysphoria often experience significant distress and have a strong desire for gender reassignment treatment.